Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS Australia (SA) Inc
 
 
Facebook
 
ME/CFS AUSTRALIA (SA) INC

Registered Charity 3104

Email:
sacfs@sacfs.asn.au

Mailing address:
PO Box 28,
Hindmarsh,
South Australia 5007

Office:
Suite 506,
North Terrace House,
19 North Terrace,
Hackney, SA, 5069


Phone:
1300 128 339

Office Hours:
Wednesdays, 11am-3pm

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
PDF Application Form (PDF, 242KB)
Why become a member?

New hope for fighting Fibromyalgia pain

Wednesday 28 September 2011

From ThirdAge.com:

 

Woman in painNew Hope For Fighting Fibromyalgia Pain

Muscle Relaxant May Ease Fibromyalgia Pain

Posted by Robin Westen on September 22, 2011 5:16 PM

Around five million Americans suffer with fibromyalgia, a disorder that causes muscle pain and fatigue. Most are women and the majority suffers with tender and painful points on their neck, shoulders, back, hips, arms and legs. Finally, a new study shows there may be help for those who have the condition. Low doses of the muscle relaxant Cyclobenzaprine, taken at bedtime, has been shown to not only help people with fibromyalgia sleep better and feel less pain – but may also relieve their blues.

Some doctors have already been prescribing Cyclobenzaprine (marketed in higher doses by others as Amrix, Fexmid, and Flexeril) for patients with the disorder, but they’ve been doing it ''off-label.'' This means the medicine, which has been used to ease the pains of rehabilitative physical therapy, hasn’t been approved for specifically for fibromyalgia by the FDA. But thanks to the new study from the University of Toronto, this may change. 

Researchers from the university randomly selected 18 fibromyalgia patients to take Cyclobenzaprine. Doses were increased, as needed, up to 4 milligrams a day. Another eighteen patients were given a placebo. Twenty-nine patients completed the eight-week study. At the end, the researchers found that the total sleep time increased from an average of 5.7 hours to 6.4 hours in the treated group and fatigue decreased. Other benefits were also shown for the group given the drug including a reduction in pain, tenderness and depression, all common symptoms of the condition. 

Scientists note a larger study is needed to see if the new treatment is better than existing treatments.  However, because of this study, a lower dose version of the drug is already being developed specifically to treat the symptoms of fibromyalgia. Speak with your doctor about it.

 

The above originally appeared here.

 


 

blog comments powered by Disqus

Previous Previous Page